These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37888229)

  • 21. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.
    Chryssanthou E; Cuenca-Estrella M
    J Clin Microbiol; 2002 Oct; 40(10):3841-4. PubMed ID: 12354895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
    Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
    Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.
    Arendrup MC; Prakash A; Meletiadis J; Sharma C; Chowdhary A
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416539
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.
    Lamoth F; Alexander BD
    J Clin Microbiol; 2015 Oct; 53(10):3176-81. PubMed ID: 26202113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
    Chryssanthou E; Cuenca-Estrella M
    Clin Microbiol Infect; 2006 Sep; 12(9):901-4. PubMed ID: 16882296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Etest performed in Mueller-Hinton agar supplemented with glucose for antifungal susceptibility testing of clinical isolates of filamentous fungi.
    Pinto E; Lago M; Branco L; Vale-Silva LA; Pinheiro MD
    Mycopathologia; 2014 Apr; 177(3-4):157-66. PubMed ID: 24570038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of fungal susceptibility testing.
    Posteraro B; Sanguinetti M
    Future Microbiol; 2014; 9(8):947-67. PubMed ID: 25302953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Jean SS; Yang HJ; Hsieh PC; Huang YT; Ko WC; Hsueh PR
    Microbiol Spectr; 2022 Dec; 10(6):e0296522. PubMed ID: 36314941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems.
    Pellaton N; Sanglard D; Lamoth F; Coste AT
    Front Cell Infect Microbiol; 2022; 12():859439. PubMed ID: 35601096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing.
    Ceballos-Garzon A; Garcia-Effron G; Cordoba S; Rodriguez JY; Alvarez-Moreno C; Pape PL; Parra-Giraldo CM; Morales-López S
    Int J Antimicrob Agents; 2022 Apr; 59(4):106558. PubMed ID: 35227828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
    Mammen MD; Sahni RD; Varghese GM; Rupa V
    Indian J Med Microbiol; 2021 Jul; 39(3):328-333. PubMed ID: 33906748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.
    Arendrup MC; Meletiadis J; Mouton JW; Guinea J; Cuenca-Estrella M; Lagrou K; Howard SJ;
    Clin Microbiol Infect; 2016 Jun; 22(6):571.e1-4. PubMed ID: 26851656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates.
    Metin DY; Hilmioglu-Polat S; Samlioglu P; Doganay-Oflazoglu B; Inci R; Tumbay E
    Mycopathologia; 2011 Sep; 172(3):187-99. PubMed ID: 21424603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole.
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW;
    Clin Microbiol Infect; 2012 Jul; 18(7):E248-50. PubMed ID: 22540149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
    Bourgeois N; Dehandschoewercker L; Bertout S; Bousquet PJ; Rispail P; Lachaud L
    J Clin Microbiol; 2010 Jan; 48(1):154-61. PubMed ID: 19889902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against
    Melhem MSC; Coelho VC; Fonseca CA; Oliveira L; Bonfietti LX; Szeszs MW; Magri MMC; Dorneles FS; Taguchi H; Moreira DVS; Motta AL; Batista MV; Kamei K; Shikanai-Yasuda MA
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.
    Beyer R; Spettel K; Zeller I; Lass-Flörl C; Achleitner D; Krause R; Apfalter P; Buzina W; Strauss J; Gregori C; Schüller C; Willinger B
    Mycoses; 2019 Apr; 62(4):357-367. PubMed ID: 30636016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria.
    Aigner M; Erbeznik T; Gschwentner M; Lass-Flörl C
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.